反応式
Cl.[NH2:2][CH:3]1[CH2:11][C:10]2[C:5](=[CH:6][CH:7]=[C:8](/[CH:12]=[CH:13]/[C:14]3[CH:19]=[CH:18][C:17]([CH3:20])=[CH:16][CH:15]=3)[CH:9]=2)[CH2:4]1.C(N(CC)CC)C.Cl[C:29]1[C:30]2[C:37]([CH3:38])=[CH:36][S:35][C:31]=2[N:32]=[CH:33][N:34]=1>C(O)C>[CH3:20][C:17]1[CH:16]=[CH:15][C:14](/[CH:13]=[CH:12]/[C:8]2[CH:9]=[C:10]3[C:5](=[CH:6][CH:7]=2)[CH2:4][CH:3]([NH:2][C:29]2[C:30]4[C:37]([CH3:38])=[CH:36][S:35][C:31]=4[N:32]=[CH:33][N:34]=2)[CH2:11]3)=[CH:19][CH:18]=1参加物
5
実験手順
Using 2-amino-5-[(E)-2-(4-methylphenyl)ethenyl]indan hydrochloride (16 mg, 0.06 mmol), ethanol (0.6 ml), triethylamine (50 μl, 0.36 mmol), and 4-chloro-5-methylthieno[2,3-d]pyrimidine (11 mg, 0.060 mmol), a similar procedure to b) in Production Example 208 was carried out The product obtained was purified by silica gel chromatography (hexane:ethyl acetate=4:1) to obtain the title compound (14 mg, 0.035 mmol) having the following physical properties:
後処理
- customobtained
- customwas purified by silica gel chromatography (hexane:ethyl acetate=4:1)
出典と根拠
- ORDレコード
- ord-134ae1cc6abb455f8150da7402ee78a5
- 出典データセット
- uspto-grants-2004_03
- 特許番号
- US06703421B1
関連ノート
読み込み中…